Aurora Cannabis (ACB) Gains from Investment Securities (2017 - 2024)

Aurora Cannabis (ACB) has reported Gains from Investment Securities for 7 consecutive years, with -$2.2 million the latest figure, recorded in Q4 2024.

• Quarterly Gains from Investment Securities fell 0.86% year-over-year to -$2.2 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$7.3 million (down 137.13% YoY) and the FY2023 annual result came in at $1.6 million, up 204.72% from the prior year.
• Gains from Investment Securities retreated to -$2.2 million in Q4 2024 per ACB's latest filing, from -$1.2 million in the prior quarter.
• Over the last five years, Gains from Investment Securities for ACB reached as high as $8.7 million in Q1 2020 and fell as low as -$2.6 million in Q2 2020.
• A 4-year average of -$557625.3 and a median of -$1.6 million in 2022 frame the typical range for Gains from Investment Securities.
• Annual changes were most pronounced in 2023 — Gains from Investment Securities slumped 2958.32% — and 2024, when it slipped 0.86%.
• Year by year, Gains from Investment Securities stood at -$2.6 million in 2020, then jumped by 97.22% to -$72196.9 in 2022, then sank by 2958.32% to -$2.2 million in 2023, then decreased by 0.86% to -$2.2 million in 2024.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered -$2.2 million, -$1.2 million, and -$1.7 million for Q4 2024, Q3 2024, and Q2 2024 respectively.